Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Evaluates enhanced chemiluminescence detection in plasma samples, indicating improved diagnostics efficacy.
). By systematically varying the initiator loading and monomer feed, a clear structure-property relationship is established between brush architecture, surface carboxyl density, antibody immobilization, and interfacial sensing performance. The optimized beads achieve a 23-fold enhancement in chemiluminescence intensity and increase the signal-to-background ratio from 79 to 575 for creatine kinase MB (CK-MB) detection, with a limit of detection of 0.11 ng/mL. The analytical performance is rigorously evaluated, and the method is validated using 50 clinical plasma samples, demonstrating the robustness of the engineered biointerface for practical diagnostic applications.
Nie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: